Endomyocardial Fibrosis Secondary to Chronic Eosinophilic Leukemia: Case Report

Article Sidebar

PDF
Published: May 16, 2024
DOI: https://doi.org/10.47191/ijmscrs/v4-i05-13
Keywords:
Endomyocardial Fibrosis; Restrictive Cardiomyopathy; Cardiovascular Abnormalities; Hypereosinophilic Syndrome; Leukemia.

Main Article Content

Yasmin Tourinho Delmondes Trindade
Universidade Tiradentes, Departamento de Medicina, Aracaju, Sergipe, Brazil
Caio Oliveira Bastos
Universidade Federal de São Paulo, Brazil
Mariana Garcez da Cruz
Universidade de São Paulo, Brazil
Leda Maria Delmondes Freitas Trindade
Universidade Tiradentes, Departamento de Medicina, Aracaju, Sergipe, Brazil
Luiz Flávio Galvão Gonçalves
Universidade Federal de Sergipe, Departamento de Medicina, Aracaju, Sergipe, Brazil & Rede D’Or São Luiz, Clínica e Hospital São Lucas, Aracaju, Sergipe, Brazil & Universidade Federal de Sergipe, Hospital Universitário, Divisão de Cardiologia, Aracaju, Sergipe, Brazil
José Augusto Soares Barreto Filho
Universidade Federal de Sergipe, Departamento de Medicina, Aracaju, Sergipe, Brazil & Rede D’Or São Luiz, Clínica e Hospital São Lucas, Aracaju, Sergipe, Brazil & Universidade Federal de Sergipe, Hospital Universitário, Divisão de Cardiologia, Aracaju, Sergipe, Brazil
Milena dos Santos Barros Campos
Universidade Tiradentes, Departamento de Medicina, Aracaju, Sergipe, Brazil & Universidade Federal de Sergipe, Departamento de Medicina, Aracaju, Sergipe, Brazil & Rede D’Or São Luiz, Clínica e Hospital São Lucas, Aracaju, Sergipe, Brazil & Universidade Federal de Sergipe, Hospital Universitário, Divisão de Cardiologia, Aracaju, Sergipe, Brazil

Abstract

Endomyocardial fibrosis (EMF) is characterized by fibrosis of the endomyocardium of one or both ventricles and atrioventricular valves. Progressive fibrosis leads to irreversible restrictive cardiomyopathy, progressing to heart failure (HF), thromboembolic phenomena, and arrhythmias. It is one of the main complications of chronic eosinophilic leukemia (CEL), resulting from intense eosinophilic infiltration into cardiac tissue. This case is of a 34-year-old male patient with past medical history of CEL, who developed EMF and severe heart failure, NYHA (New York Heart Association) IV, and underwent endocardectomy and mitral and tricuspid valvuloplasty. After the procedure, he improved to NYHA II, initiated cardiovascular rehabilitation, and returned to daily activities.

Article Details

How to Cite
Tourinho Delmondes Trindade, Y., Oliveira Bastos , C. ., Garcez da Cruz , M. ., Maria Delmondes Freitas Trindade, L. ., Flávio Galvão Gonçalves , L. ., Augusto Soares Barreto Filho, J. ., & dos Santos Barros Campos, M. . (2024). Endomyocardial Fibrosis Secondary to Chronic Eosinophilic Leukemia: Case Report. International Journal of Medical Science and Clinical Research Studies, 4(05), 845–848. https://doi.org/10.47191/ijmscrs/v4-i05-13
Issue
Vol. 4 No. 05 (2024): Volume 04 Issue 05 May 2024
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Sutter J, Suboc T, Rao A. Tropical Endomyocardial Fibrosis. J Am Coll Cardiol Case Rep. 2020; 2(5)819–822.

II. Junior JCR, Hamdan SMM. Idiopathic endocardiomyofibrosis complicated with the performance of invasive procedure: case report. Revista Eletrônica Acervo Científico. 2020;9:e3286.

III. Sapalo AT, Cunha R, Gali LG, Romano MMD. Apical Occupation by Endomyocardiofibrosis Associated with Thrombus Diagnosed with Contrast Echocardiography and Resolved with Clinical Treatment. Arq Bras Cardiol: Imagem cardiovasc. 2022;35(4):eabc349.

IV. Grimaldi A, Mocumbi AO, Freers J, Lachaud M, Mirabel M, Ferreira B, Narayanan K, Celermajer DS, Sidi D, Jouven X, Marijon E. Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives. Circulation. 2016;133(24):2503-2515.

V. Hastenteufel LCT, Clausell NO, Oliveira FH de, Leitão SAT, Goldraich LA. Endomyocardial Fibrosis as a Rare Cause of Heart Transplantation and its Association with Thrombophilia: A Case Report. Arq Bras Cardiol. 2022;118(1):103–5.

VI. Isper KFS, Arakaki RN, Rosseto F, Ebaid HIA. Case history of right ventricular endomyocardial fibrosis in a nonagenarian patient. Rev Soc Cardiol Estado de São Paulo. 2019;29(3):324-7.

VII. Chauffaille M de LLF. Reactive eosinophilia, chronic eosinophilic leukemia and idiopathic hypereosinophilic syndrome. Rev Bras Hematol Hemoter. 2010;32(5):395–401.

VIII. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, Hellmann A, Metzgeroth G, Leiferman KM, Arock M, Butterfield JH, Sperr WR, Sotlar K, Vandenberghe P, Haferlach T, Simon HU, Reiter A, Gleich GJ. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol. 2012;130(3):607-612.e9.

IX. Balanchivadze N, Purtell JP, Anderson J, Guo Y, Dobrosotskaya I. A Case of Chronic Eosinophilic Leukemia in a Patient With Recurrent Cough, Dyspnea, and Eosinophilia. Cureus. 2021;13(1):e12654.

X. Soares RR, Avelar MCM, Zanetti SL, Garreto JVTM, Guimaraes VD, Ferber ES, Drumond MO, Ferber M, Ferber L. Left ventricle endomyocardial fibrosis: a case report. J Med Case Reports. 2023;17:361.

XI. Oish GSL, Nastari RR, Rocha RG, Leguizamon JAGO, Salemi VMC, Hotta VT. Endomyocardial fibrosis: How to diagnose and treat?. Rev Soc Cardiol Estado de São Paulo. 2023;33(3):312-319.

XII. Syed IS, Martinez MW, Feng DL, Glockner JF. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol. 2008 Jun 6;126(3):e50-2.

XIII. Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Stephan BF, et al. Current state of knowledge on a etiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. European Heart Journal. 2013;34, 2636–2648.

XIV. Torres CD, Chandía M. Sustained hematologic response in chronic eosinophilic leukemia with low dose imatinib. Report of one case. Rev. méd. Chile. 2014;142(4): 516-520.

XV. Filho JR, Souza CAF, Magrini E, Macedo M, Isolato RB. Biventricular Endomyocardiofibrosis Associated with Renal Amyloidosis. Arq. Bras. Cardiol. 2005;84(4):275-278.